Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Diabetology International
Erschienen in: Diabetology International 1/2022

08.11.2021 | Report of the Committee

Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity

verfasst von: Akira Sasaki, Koutaro Yokote, Takeshi Naitoh, Junji Fujikura, Karin Hayashi, Yushi Hirota, Nobuya Inagaki, Yasushi Ishigaki, Kazunori Kasama, Eri Kikkawa, Hidenori Koyama, Hiroaki Masuzaki, Takeshi Miyatsuka, Takehiro Nozaki, Wataru Ogawa, Masayuki Ohta, Shinichi Okazumi, Michio Shimabukuro, Iichiro Shimomura, Hitoshi Nishizawa, Atsuhito Saiki, Yosuke Seki, Nobuhiro Shojima, Motoyoshi Tsujino, Satoshi Ugi, Hiroaki Watada, Toshimasa Yamauchi, Takashi Yamaguchi, Kohjiro Ueki, Takashi Kadowaki, Ichiro Tatsuno, Joint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, the Japan Society for the Study of Obesity

Erschienen in: Diabetology International | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Bariatric surgery has been shown to have a variety of metabolically beneficial effects for patients with type 2 diabetes (T2D), and is now also called metabolic surgery. At the 2nd Diabetes Surgery Summit held in 2015 in London, the indication for bariatric and metabolic surgery was included in the “algorithm for patients with type T2D”. With this background, the Japanese Society for Treatment of Obesity (JSTO), the Japan Diabetes Society (JDS) and the Japan Society for the Study of Obesity (JASSO) have formed a joint committee to develop a consensus statement regarding bariatric and metabolic surgery for the treatment of Japanese patients with T2D. Eventually, the consensus statement was announced at the joint meeting of the 38th Annual Meeting of JSTO and the 41st Annual Meeting of JASSO convened in Toyama on March 21, 2021. In preparing the consensus statement, we used Japanese data as much as possible as scientific evidence to consider the indication criteria, and set two types of recommendation grades, “recommendation” and “consideration”, for items for which recommendations are possible. We hope that this statement will be helpful in providing evidence-based high-quality care through bariatric and metabolic surgery for the treatment of obese Japanese patients with T2D.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Examination Committee of Criteria for ‘Obesity Disease’ in Japan; Japan Society for the Study of Obesity. New Criteria for ‘Obesity Disease’ in Japan. Circ J. 2002;66:987–92
3.
Sjöström L, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.PubMed
4.
Cardoso L, et al. Short- and long-term mortality after bariatric surgery: a systematic review and meta-analysis. Diabetes Obes Metab. 2017;19:1223–32.PubMed
5.
Syn NL, et al. Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174772 participants. Lancet. 2021;397:1830–41.PubMed
6.
Rubino F, Delegates of the 2nd Diabetes Surgery Summit, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861–77.PubMed
7.
Japan Society for the Study of Obesity. Guidelines for the management of obesity disease. Tokyo: Life Science Publishing; 2016. (in Japanese).
8.
Japan Diabetes Society. Treatment guideline for diabetes 2020–2021. Tokyo: Bunkodo; 2020. (in Japanese)
9.
Japan Diabetes Society. Japanese Clinical Practice Guideline for Diabetes 2019. Tokyo: Nankodo; 2019. (in Japanese)
10.
Montesi L, et al. Long-term weight loss maintenance for obesity: a multidisciplinary approach. Diabetes, Metabolic Syndrome And Obesity. Targets Therapy. 2016;9:27–46.
11.
The Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Executive summary: guidelines (2013) for the management of overweight and obesity in adults. Obesity. 2014;22:S5–39.
12.
Toyama T, et al. Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis. Diabetes Obes Metab. 2019;21:1237–50.
13.
Cai X, et al. The association between the dosage of SGLT2 inhibitor and weight reduction in type 2 diabetes patients: a meta-analysis. Obesity (Silver Spring). 2018;26:70–80.
14.
Monami M, et al. Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis. Exp Diabetes Res. 2012;2012:672658.PubMedPubMedCentral
15.
Potts JE, et al. The effect of glucagon-like peptide 1 receptor agonists on weight loss in type 2 diabetes: a systematic review and mixed treatment comparison meta-analysis. PLoS ONE. 2015;10: e0126769.PubMedPubMedCentral
16.
Izzi-Engbeaya C, et al. Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals. BMJ Open Diab Res Care. 2021;9: e001858.PubMed
17.
Anderson MR, et al. Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Ann Intern Med. 2020;173:782–90.PubMed
18.
Shoar S, et al. Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus roux-en-y gastric bypass: a systematic review and meta-analysis of comparative studies. Surg Obes Relat Dis. 2017;13:170–80.PubMed
19.
Yan Y, et al. Roux-en-Y gastric bypass versus medical treatment for type 2 diabetes mellitus in obese patients: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95: e3462.
20.
Ribaric G, et al. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review. Obes Surg. 2014;24:437–55.PubMed
21.
Chang SH, et al. The Effectiveness and risk of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149:275–87.PubMedPubMedCentral
22.
Mental Health Subcommittee in Japan Society for Treatment of Obesity. Understanding and dealing with psychosocial problems necessary for obesity treatment (ed). Tokyo: Compus; 2016. (in Japanese)
23.
Hayashi K, et al. Psychiatric disorders with obesity patients: mainly depression. Jpn J Psychosom Int Med. 2016;20:267–72 (in Japanese).
24.
Rubio F, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26:485–97.
25.
Caterson ID, et al. Gaps to bridge: misalignment between perception, reality and actions in obesity. Diabetes Obes Metab. 2019;21:1914–24.PubMedPubMedCentral
26.
27.
Locke AE, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206.PubMedPubMedCentral
28.
Akiyama M, et al. Genome-wide association study identifies 112 loci for body mass index in the Japanese population. Nat Genet. 2017;49:1458–67.PubMed
29.
Spracklen CN, et al. Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature. 2020;582:240–5.PubMedPubMedCentral
30.
Kasama K, et al. IFSO-APC consensus statement 2011. Obes Surg. 2012;22:677–84.PubMed
31.
American Diabetes Association. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Supplement 1):S89–97.
32.
33.
Mingrone G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386:964–73.PubMed
34.
Schauer PR, STAMPEDE Investigators, et al. Bariatric surgery versus intensive medical therapy for diabetes 3-year outcomes. N Engl J Med. 2014;370:2002–13.PubMedPubMedCentral
35.
Ribaric G, et al. Diabetes and weight comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014;24:437–55.PubMed
36.
Carlsson LMS, et al. Life expectancy after bariatric surgery in the Swedish obese subjects study. N Engl J Med. 2020;383:1535–43.PubMedPubMedCentral
37.
Aminian A, et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA. 2019;322:1271–82.PubMedPubMedCentral
38.
Yan G, et al. Long-term outcomes of macrovascular diseases and metabolic indicators of bariatric patients with a meta-analysis. PLoS ONE. 2019;14: e0224828.PubMedPubMedCentral
39.
Sjöström L, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297–304.
40.
Sheng B, et al. The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular complications, and mortality: a systemic review and meta-analysis. Obes Surg. 2017;27:2724–32.PubMed
41.
Upala S, et al. Bariatric surgery reduces urinary albumin exertion in diabetic nephropathy: a systemic review and meta-analysis. Surg Obes Relat Dis. 2016;12:1037–44.PubMed
42.
Lindekilde N, et al. The impact of bariatric surgery on quality of life: a systematic review and meta-analysis. Obes Rev. 2015;16:639–51.PubMed
43.
Seki Y, et al. Long-term outcomes of laparoscopic sleeve gastrectomy in morbidly obese Japanese patients. Obes Surg. 2016;26:138–45.PubMed
44.
Haruta H, et al. Long-term outcomes of bariatric and metabolic surgery in Japan: results of a multi-institutional survey. Obes Surg. 2017;27:754–62.PubMed
45.
Saiki A, et al. Background characteristics and postoperative outcomes of insufficient weight loss after laparoscopic sleeve gastrectomy in Japanese patients. Ann Gastroenterol Surg. 2019;26:638–47.
46.
Naitoh T, et al. Efficacy of sleeve gastrectomy with duodenal-jejunal bypass for the treatment of obese severe diabetes patients in Japan: a retrospective multicenter study. Obes Surg. 2018;28:497–505.PubMed
47.
Umemura A, et al. Prognostic factors and a new preliminary scoring system for remission of type 2 diabetes mellitus after laparoscopic sleeve gastrectomy. Surg Today. 2020;50:1056–64.PubMed
48.
49.
Heymsfield SB, et al. Mechanisms, pathophysiology, and management of obesity. NEJM. 2017;376:254–66.PubMed
50.
Simon GE, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006;63:824–30.PubMedPubMedCentral
51.
Saiki A, et al. Impact of mental health background and nutrition intake on medium-term weight loss in Japanese patients undergoing laparoscopic sleeve gastrectomy. Obes Facts. 2020;13:371–83.PubMedPubMedCentral
52.
Sarwer DB, et al. Psychopathology, disordered eating, and impulsivity as predictors of outcomes of bariatric surgery. Surg Obes Relat Dis. 2019;15:650–5.PubMedPubMedCentral
53.
Yu Y, et al. Predictors of weight regain after sleeve gastrectomy: an integrative review. Surg Obes Relat Dis. 2019;15:995–1005.PubMed
54.
Sogg S, et al. Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients. Surg Obes Relat Dis. 2016;12:731–49.PubMed
55.
Mechanick JI, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient: 2013 Update. Endocr Pract. 2013;19:e1–36.
56.
Eldar S, et al. A focus on surgical preoperative evaluation of the bariatric patient—the Cleveland Clinic protocol and review of the literature. Surgeon. 2011;9:273–7.PubMed
57.
Hout GCM, et al. Psychosocial predictors of success following bariatric surgery. Obes Surg. 2005;15:552–60.PubMed
58.
Pull CB. Current psychological assessment practices in obesity surgery programs: what to assess and why. Curr Opin Psychiatry. 2010;23:30–6.PubMed
59.
Fabricatore AN, et al. How do mental health professionals evaluate candidates for bariatric surgery? Survey results. Obes Surg. 2005;15:567–73.
60.
Mechanick JI, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures–2019 update. Endocr Pract. 2019;25:1346–59.PubMed
61.
62.
Rubino F, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26:485–97.PubMedPubMedCentral
63.
Arora M, et al. Stigma and obesity: the crux of the matter. Lancet Public Health. 2019;4:E549–50.PubMed
64.
Albury C, et al. The importance of language in engagement between health-care professionals and people living with obesity: a joint consensus statement. Lancet Diabetes Endocrinol. 2020;8:447–55.PubMed
65.
Spahlholz J, et al. Obesity and discrimination: a systematic review and meta-analysis of observational studies. Obes Rev. 2016;17:43–55.PubMed
66.
Kaly P, et al. Unrealistic weight loss expectations in candidates for bariatric surgery. Surg Obes Relat Dis. 2008;4:6–10.PubMed
67.
Lier HØ, et al. Psychiatric disorders and participation in pre- and postoperative counselling groups in bariatric surgery patients. Obes Surg. 2011;21:730–7.PubMed
68.
Sawamoto R, et al. Predictors of successful long-term weight loss maintenance: a two-year follow-up. BioPsychoSoc Med. 2017;11:14.PubMedPubMedCentral
69.
Dawes AJ, et al. Mental health conditions among patients seeking and undergoing bariatric surgery. A meta-analysis. JAMA. 2016;315:150–63.PubMed
70.
Cassin S, et al. Psychometric properties of the Patient Health Questionnaire (PHQ-9) as a depression screening tool for bariatric surgery candidates. Psychosomatics. 2013;54:352–8.PubMed
71.
Pinto TF, et al. Obesity, hypersomnolence, and quality of sleep: the impact of bariatric surgery. Obes Surg. 2017;27:1775–9.PubMed
72.
Grupski AE, et al. Examining the binge eating scale in screening for binge eating disorder in bariatric surgery candidates. Obes Surg. 2013;23:1–6.PubMedPubMedCentral
73.
Oyama T, et al. High lambda style as pathognomonic personality of obesity patients: analysis with rorschach test. J Jpn Soc Study Obes. 2009;15:39–44.
74.
Hayashi K, et al. Psychological characteristics of obesity patientsfrom the analysis of rorschach variables. Jpn J Psychosom Med. 2016;56:920–30.
75.
Wimmelmann CL, et al. Association of personality with body mass index and obesity in a large late midlife community sample. Obes Facts. 2018;11:129–43.PubMedPubMedCentral
76.
Provost DA. Indications and contraindications for bariatric surgery. In: Nugyen NT, editor. The ASMBS textbook of bariatric surgery. 1st ed. New York: Springer; 2015. p. 73–6.
77.
De Luca M, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2020;26:1659–96.
78.
Fried M, et al. Interdisciplinary European Guidelines On Metabolic And Bariatric Surgery. Obes Facts. 2013;6:449–68.PubMedPubMedCentral
79.
80.
Clark MM, et al. Psychosocial factors and 2-year outcome following bariatric surgery for weight loss. Obes Surg. 2003;13:739–45.PubMed
81.
Heinberg L, et al. History of substance abuse relates to improved postbariatric body mass index outcomes. Surg Obes Relat Dis. 2010;6:417–21.PubMed
82.
Applegate KL, et al. Introduction to psychological consultations for bariatric surgery patients. In: Still C, Sarwer DB, Blankenship J, editors., et al., The ASMBS textbook of bariatric surgery. 2nd ed. New York: Springer; 2014. p. 33–42.
83.
Peterhänsel C, et al. Obesity and co-morbid psychiatric disorders as contraindications for bariatric surgery? Int J Surg Case Rep. 2014;5:1268–70.PubMedPubMedCentral
84.
American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(Supplement 1):S11-61.PubMedCentral
85.
Melissas J. IFSO guidelines for safety, quality, and excellence in bariatric surgery. Obes Surg. 2008;18:497–500.PubMed
86.
SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Endosc. 2008;22:2281–300.
87.
88.
89.
Treatment Guideline Committee in Japanese Society for Treatment of Obesity. Comprehensive treatment guide for obesity disease. Compass publishing, 2013 (in Japanese)
90.
91.
Sasaki A, et al. Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes. J Gastroenterol. 2014;49:57–63.PubMed
92.
Kasama K, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 2009;19:1341–5.PubMed
93.
Cresci B, et al. Metabolic surgery for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2020;22:1378–87.PubMed
94.
Cummings DE, et al. Bariatric/metabolic surgery to treat type 2 DIABETES in patients with a BMI < 35 kg/m2. Diabetes Care. 2016;39:924–33.PubMedPubMedCentral
95.
Schauer PR, et al. Bariatric surgery versus intensive medical therapy for diabetes: 5-year outcomes. N Engl J Med. 2017;376:641–51.PubMedPubMedCentral
96.
97.
Capoccia D, et al. Long-term metabolic effects of laparoscopic sleeve gastrectomy. Obes Surg. 2018;28:2289–96.PubMed
98.
Vidal J, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008;18:1077–82.PubMed
99.
Capoccia D, et al. Weight regain and diabetes evolution after sleeve gastrectomy: a cohort study with over 5 years of follow-up. Obes Surg. 2020;30:1046–51.PubMed
100.
Viscido G, et al. Obese patients with type 2 diabetes: outcomes after laparoscopic sleeve gastrectomy. J Laparoendosc Adv Surg Tech A. 2019;29:655–62.PubMed
101.
Ramos-Levi AM, et al. Statistical models to predict type 2 diabetes remission after bariatric surgery. J Diabetes. 2014;6:472–7.PubMed
102.
103.
Lee WJ, et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013;9:379–84.PubMed
104.
Seki Y, et al. The effects of laparoscopic sleeve gastrectomy with duodenojejunal bypass on Japanese patients with BMI < 35 kg/m2 on type 2 diabetes mellitus and the prediction of successful glycemic control. Obes Surg. 2018;28:2429–38.PubMed
105.
Seki Y, et al. Metabolic surgery for inadequately controlled type 2 diabetes in nonseverely obese Japanese: a prospective, single-center study. Surg Obes Relat Dis. 2018;14:978–85.PubMed
106.
Lee MH, et al. Laparoscopic sleeve gastrectomy for type 2 diabetes mellitus: long-term result and recurrence of diabetes. Obes Surg. 2020;30:3669–74.PubMed
107.
Lee WJ, et al. Metabolic surgery for diabetes treatment: sleeve gastrectomy or gastric bypass? World J Surg. 2017;41:216–23.PubMed
108.
Lee WJ, et al. Laparoscopic sleeve gastrectomy for type 2 diabetes mellitus: predicting the success by ABCD score. Surg Obes Relat Dis. 2015;11:991–6.PubMed
109.
Still CD, et al. A probability score for preoperative prediction of type 2 diabetes remission following RYGB surgery. Lancet Diabetes Endocrinol. 2014;2:38–45.PubMedPubMedCentral
110.
Aron-Wisnewsky J, et al. The advanced-DiaRem score improves prediction of diabetes remission 1 year post Roux-en-Y gastric bypass. Diabetologia. 2017;60:1892–902.PubMed
111.
Aminian A, et al. Individualized metabolic surgery score: procedure selection based on diabetes severity. Ann Surg. 2017;266:650–7.PubMed
112.
Pucci A, et al. Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. Diabetes Med. 2018;35:360–7.
113.
Ohta M, et al. Prediction of long-term diabetes remission after metabolic surgery in obese East Asian patients: a comparison between ABCD and IMS scores. Obes Surg. 2021;31:1485–95.PubMed
114.
Cotillard A, et al. Type 2 diabetes remission after gastric bypass: what is the best prediction tool for clinicians? Obes Surg. 2015;25:1128–32.PubMed
115.
Lee WJ, et al. Preoperative prediction of type 2 diabetes remission after gastric bypass surgery: a comparison of DiaRem scores and ABCD scores. Obes Surg. 2016;26:2418–24.PubMed
116.
Chen JC, et al. Prediction of type 2 diabetes remission after metabolic surgery: a comparison of the individualized metabolic surgery score and the ABCD score. Surg Obes Relat Dis. 2018;14:640–5.PubMed
117.
Shen SC, et al. Validating risk prediction models of diabetes remission after sleeve gastrectomy. Obes Surg. 2019;29:221–9.PubMed
118.
Ohta M, et al. Current status of laparoscopic bariatric/metabolic surgery in Japan: the sixth nationwide survey by the Japan Consortium of Obesity and Metabolic Surgery. Asian J Endosc Surg. 2021;14:170–7.PubMed
119.
Ding L, et al. Comparative effectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials. Obes Rev. 2020;21: e13030.PubMedPubMedCentral
120.
Park CH, et al. Comparative efficacy of bariatric surgery in the treatment of morbid obesity and diabetes mellitus: a systematic review and network meta-analysis. Obes Surg. 2019;29:2180–90.PubMed
121.
Lee Y, et al. Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass: a systematic review and meta-analysis of weight loss, comorbidities, and biochemical outcomes from randomized controlled trials. Ann Surg. 2021;273:66–74.PubMed
122.
Parrott J, et al. Integrated health nutritional guidelines for the surgical weight loss patient-2016 update: micronutrients. Surg Obes Relat Dis. 2017;13:727–41.PubMed
123.
Nicoletti CF, et al. New look at nutritional care for obese patient candidates for bariatric surgery. Surg Obes Relat Dis. 2013;9:520–5.PubMed
124.
Jastrzębska-Mierzyńska M, et al. Assessment of dietary habits, nutritional status and blood biochemical parameters in patients prepared for bariatric surgery: a preliminary study. Wideochir Inne Tech Maloinwazyjne. 2012;7:156–65.PubMedPubMedCentral
125.
Lo Menzo E, et al. A nutritional implications of obesity: before and after bariatric surgery. Bariatr Surg Pract Patient Care. 2014;9:9–17.PubMedPubMedCentral
126.
Watanabe A, et al. Preoperative weight loss and operative outcome after laparoscopic sleeve gastrectomy. Obes Surg. 2017;27:2515–21.PubMed
127.
Mechanick JI, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures–2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, the Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of AnesthesiologistsExecutive Summary. Endocr Pract. 2019;25:1346–59.PubMed
128.
Collins J, et al. Preoperative weight loss in high-risk superobese bariatric patients: a computed tomographybased analysis. Surg Obes Relat Dis. 2011;7:480–5.PubMed
129.
Fris RJ. Preoperative low energy diet diminishes liver size. Obes Surg. 2004;14:1165–70.PubMed
130.
Colles SL, et al. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84:301–11.
131.
Holderbaum M, et al. Effects of very low calorie diets on liver size and weight loss in the preoperative period of bariatric surgery: a systematic review. Surg Obes Relat Dis. 2018;14:237–44.PubMed
132.
Wissen J, et al. Preoperative methods to reduce liver volume in bariatric surgery: a systematic review. Obes Surg. 2016;26:251–6.PubMed
133.
Alvarado R, et al. The impact of preoperative weight loss in patients undergoing laparoscopic roux-en-Y gastric bypass. Obes Surg. 2005;15:1282–6.PubMed
134.
Conaty EA, et al. Efficacy of a required preoperative weight loss program for patients undergoing bariatric surgery. J Gastrointest Surg. 2016;20:667–73 (in Japanese).PubMed
135.
Japan Diabetes Society. Diabetes specialist training guidebook 8th ed. 2020. (in Japanese)
136.
137.
Dhatariya K, et al. NHS guideline for the perioperative management of the adult patient with diabetes. Diabetes Med. 2012;29:420–33.
138.
139.
ASMBS Clinical Issues Committee. Peri-operative management of obstructive sleep apnea. Surg Obes Relat Dis. 2012;8:e27-32.
140.
Hallowell PT, et al. Potentially life-threatening sleep apnea is unrecognized without aggressive evaluation. Am J Surg. 2007;193:364–7.PubMed
141.
Frey WC, et al. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg. 2003;13:676–83.PubMed
142.
Chung F, et al. Society of anesthesia and sleep medicine guidelines on preoperative screening and assessment of adult patients with obstructive sleep apnea. Anesth Analg. 2016;123:452–73.PubMedPubMedCentral
143.
Abdelsattar ZM, et al. The impact of untreated obstructive sleep apnea on cardiopulmonary complications in general and vascular surgery: a cohort study. Sleep. 2015;38:1205–10.PubMedPubMedCentral
144.
145.
James E, et al. Psychopathology before surgery in the Longitudinal Assessment of Bariatric Surgery-3(LABS3) Psychosocial Study. Surg Obes Relat Dis. 2012;8:533–41.
146.
Luca MD, et al. Indications for surgery for obesity and weight-related diseases: position statements from the international federation for the surgery of obesity and metabolic disorders (IFSO). Obes Surg. 2016;26:1659–96.PubMedPubMedCentral
147.
Brodsky JB, et al. Morbid obesity and tracheal intubation. Anesth Analg. 2002;94:732–6.PubMed
148.
Langeron O, et al. Prediction of difficult mask ventilation. Anesthesiology. 2000;92:1229–36.PubMed
149.
Kheterpal S, et al. Incidence and predictors of difficult and impossible mask ventilation. Anesthesiology. 2006;105:885–91.PubMed
150.
DeMaria EJ, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg. 2007;246:578–82.PubMed
151.
Ogunnaike BO, et al. Anesthetic considerations for bariatric surgery. Anesth Analg. 2002;95:1793–805.PubMed
152.
Schumann R. Anaesthesia for bariatric surgery. Best Pract Res Clin Anaesthesiol. 2011;25:83–93.PubMed
153.
154.
Buchwald H, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621–32.PubMed
155.
Greenstein AJ, et al. Prevalence of adverse intraoperative events during obesity surgery and their sequelae. J Am Coll Surg. 2012;215:271–7.PubMedPubMedCentral
156.
Stenberg E, et al. Early complications after laparoscopic gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry. Ann Surg. 2014;260:1040–7.PubMed
157.
Nelson DW, et al. Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity. Arch Surg. 2012;147:847–54.PubMed
158.
Hutter MM, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254:410–20.PubMed
159.
Nguyen NT, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg. 2001;234:279–89.PubMedPubMedCentral
160.
Arterburn D, et al. Predictors of long-term mortality after bariatric surgery performed in Veterans Affairs medical centers. Arch Surg. 2009;144:914–20.PubMed
161.
Melinek J, et al. Autopsy findings following gastric bypass surgery for morbid obesity. Arch Pathol Lab Med. 2002;126:1091–5.PubMed
162.
Schauer P, et al. The learning curve for laparoscopic Roux-en-Y gastric bypass is 100 cases. Surg Endosc. 2003;17:212–5.PubMed
163.
Wittgrove AC, et al. Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3–60 month follow-up. Obes Surg. 2000;10:233–9.PubMed
164.
Schauer PR, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.PubMedPubMedCentral
165.
Westling A, et al. Laparoscopic vs open Roux-en-Y gastric bypass: a prospective, randomized trial. Obes Surg. 2001;11:284–92.PubMed
166.
Nguyen NT, et al. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg. 2000;191:149–55.PubMed
167.
Higa KD, et al. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients—what have we learned? Obes Surg. 2000;10:509–13.PubMed
168.
Papasavas PK, et al. Outcome analysis of laparoscopic Roux-en-Y gastric bypass for morbid obesity. The first 116 cases. Surg Endosc. 2002;16:1653–7.PubMed
169.
Luján JA, et al. Laparoscopic gastric bypass in the treatment of morbid obesity. Preliminary results of a new technique. Surg Endosc. 2002;16:1658–62.PubMed
170.
Mehran A, et al. Management of acute bleeding after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13:842–7.PubMed
171.
Nguyen NT, et al. Early gastrointestinal hemorrhage after laparoscopic gastric bypass. Obes Surg. 2003;13:62–5.PubMed
172.
Lancaster RT, et al. Bands and bypasses: 30-day morbidity and mortality of bariatric surgical procedures as assessed by prospective, multi-center, risk-adjusted ACS-NSQIP data. Surg Endosc. 2008;22:2554–63.PubMed
173.
Carlin AM, et al. The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity. Ann Surg. 2013;257:791–7.PubMed
174.
Aurora AR, et al. Sleeve gastrectomy and the risk of leak: a systematic analysis of 4888 patients. Surg Endosc. 2012;26:1509–15.PubMed
175.
Dick A, et al. Gastrointestinal bleeding after gastric bypass surgery: nuisance or catastrophe? Surg Obes Relat Dis. 2010;6:643–7.PubMed
176.
Chapman A, Game P, O'Brien P, Maddern G, Kiroff G, Foster B et al. A systematic review of laparoscopic adjustable gastric banding for the treatment of obesity (update and re-appraisal). Adelaide, SA: Australian Safety and Efficacy Register of New Interventional Procedures-Surgical (ASERNIP-S); 2002:31.
177.
Buchwald H, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMed
178.
Stephens DJ, et al. Short-term outcomes for super-super obese (BMi>or=60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass. Surg Obes Relat Dis. 2008;4:408–15.PubMed
179.
Jones KB Jr, et al. Open versus laparoscopic Roux-en-Y gastric bypass: a comparative study of over 25,000 open cases and the major laparoscopic bariatric reported series. Obes Surg. 2006;16:721–7.PubMed
180.
Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54.
181.
Tiwari MM, et al. Differences in outcomes of laparoscopic gastric bypass. Surg Obes Relat Dis. 2011;7:277–82.PubMed
182.
Higgins RM, et al. Preoperative immobility significantly impacts the risk of postoperative complications in bariatric surgery patients. Surg Obes Relat Dis. 2018;14:842–8.PubMed
183.
The Japanese Respiratory Society. Clinical Practice Guideline for Sleep Apnea Syndrome (SAS) 2020. Tokyo: Nankodo; 2020. (in Japanese)
184.
Thorell A, et al. Guidelines for perioperative care in bariatric surgery: enhanced recovery after surgery (ERAS) society recommendations. World J Surg. 2016;40:2065–83.PubMed
185.
Kikkawa E, et al. Surgical treatment for morbidly obese japanese patients: change in food intake, nutritional status and quality of life (QOL) one year after laparoscopic Roux-en-Y Gastric Bypass (LRYGB). J Jpn Society Study Obes. 2010;16:51–7 (in Japanese).
186.
Kikkawa E, et al. Nutritional management and change in dietary intake after laparoscopic Roux-en-Y gastric bypass for the treatment of morbid obesity. J Jpn Society Study Clin Nutr. 2012;34:165–71 (in Japanese).
187.
Kikkawa E, et al. Assessment of food satisfaction and food tolerance after bariatric surgery. J Jpn Soc Metab Clin Nutr. 2016;19:415–22 (in Japanese).
188.
Kikkawa E, et al. Analysis of food satisfaction and tolerance after bariatric surgery in Japanese patients. J Jpn Soc Clin Nutr. 2015;36:10–5 (in Japanese).
189.
Kikkawa E, et al. Dietary intake after bariatric surgery in Japanese patients with severe obesity and comparison between surgical techniques. J Jpn Soc Metab Clin Nutr. 2014;16:391–6 (in Japanese).
190.
Hongo R, et al. Changes in nutrient intake and food preference before and after laparoscopic sleeve gastrectomy for patients with type 2 diabetes complicated severe obesity. Tonyobyo. 2019;62:143–54 (in Japanese).
191.
Linda A, et al. ASMBS allied health nutritional guidelines for the surgical weight loss patient. Surg Obes Relat Dis. 2008;4:73–108.
192.
Andreu A, et al. Protein intake, body composition, and protein status following bariatric surgery. Obes Surg. 2010;20:1509–15.PubMed
193.
Saiki A, et al. The effects of partial use of formula diet on nutritional deficiency after bariatric surgery in severe obese patients: 12-month follow-up study. J Jpn Society Study Clin Nutr. 2014;36:1798–1805171 (in Japanese).
194.
Kikkawa E, et al. Postoperative nutritional management and follow-up, metabolic surgery clinical update 135–140. Osaka: Medica Publishing; 2020. (in Japanese).
195.
Caron M, et al. Long-term nutritional impact of sleeve gastrectomy. Surg Obes Relat Dis. 2017;13:1664–75.PubMed
196.
Ministry of Health, Labour and Welfare. Dietary reference intakes for Japanese (2020). Tokyo: Daiichi syuppan; 2020. (in Japanese)
197.
198.
Hood MM, et al. Managing severe obesity: understanding and improving treatment adherence in bariatric surgery. J Behav Med. 2016;39:1092–103.PubMed
199.
Kushner R, et al. The American Board of Obesity Medicine: five year report. Obesity. 2017;25:982–3.PubMed
200.
Dawes AJ, et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a metaanalysis. JAMA. 2016;315:150–63.PubMed
201.
Creel DB, et al. A randomized trial comparing two interventions to increase physical activity among patients under- going bariatric surgery. Obesity (Silver Spring). 2016;24:1660–8.
202.
Courcoulas AP, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310:2416–25.PubMedPubMedCentral
203.
Mulla CM, et al. Management of diabetes in patients undergoing bariatric surgery. Curr Diabetes Rep. 2019;19:112.
204.
Aberle J, et al. Metformin after bariatric surgery: an acid problem. Exp Clin Endocrinol Diabetes. 2012;120:152–3.PubMed
205.
Kashyap SR, et al. Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: a pilot study. Obes Sci Pract. 2020;6:255–63.PubMedPubMedCentral
206.
Andalib A, et al. Diabetic ketoacidosis following bariatric surgery in patients with type2 diabetes. Diabetes Care. 2016;39:e121-122.PubMed
207.
Capristo E, et al. Incidence of hypoglycemia after gastric bypass vs sleeve gastrectomy: a randomized trial. J Clin Endocrinol Metab. 2018;103:2136–46.PubMed
208.
Sawada S, et al. Continuous glucose monitoring in patients with remission of type 2 diabetes after laparoscopic sleeve gastrectomy without or with duodenojejunal bypass. Clin Obes. 2020;10: e12409.PubMed
209.
Murphy R, et al. Progression of diabetic retinopathy after bariatric surgery. Diabet Med. 2015;32:1212–20.PubMed
210.
Choi HK, et al. Bariatric surgery as urate-lowering therapy in severe obesity. Ann Rheum Dis. 2014;73:791–3.PubMed
211.
Gadiraju S, et al. Levothyroxine dosing following bariatric surgery. Obes Surg. 2016;26:2538–42.PubMed
212.
Pellitero S, et al. Evaluation of vitamin and trace element requirements after sleeve gastrectomy at long term. Obes Surg. 2017;27:1674–82.PubMed
213.
Kwon Y, et al. Anemia, iron and vitamin B12 deficiencies after sleeve gastrectomy compared to Roux-en-Y gastric bypass: a meta-analysis. Surg Obes Relat Dis. 2014;10:589–97.PubMed
214.
Cummings DE, et al. Metabolic surgery for the treatment of type 2 diabetes in obese individuals. Diabetologia. 2018;61:257–64.PubMed
215.
Sarkhosh K, et al. The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Obes Surg. 2013;23:414–23.PubMed
216.
Dixon JB, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308:1142–9.PubMed
217.
Seki Y, et al. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. J Gastroenterol. 2016;51:281–9.PubMed
218.
Nikai H, et al. Effects of laparoscopic sleeve gastrectomy on non-alcoholic steatohepatitis and liver fibrosis in Japanese patients with severe obesity. Obes Surg. 2020;30:2579–87.PubMed
219.
Coupaye M, et al. Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass in obese patients: a prospective study. Surg Obes Relat Dis. 2015;11:779–84.PubMed
220.
Mihmanli M, et al. Effects of laparoscopic sleeve gastrectomy on parathyroid hormone, vitamin D, calcium, phosphorus, and albumin levels. Obes Surg. 2017;27:3149–55.PubMed
221.
Hewitt S, et al. Relationships between vitamin D status and PTH over 5 years after Roux-en-Y gastric bypass: a longitudinal cohort study. Obes Surg. 2020;30:3426–34.PubMedPubMedCentral
222.
Bariatric Support Centers International: BSCI Certified Support Group Leader Guidebook 21–25. Utah: Bariatric Support Centers International; 2012.
223.
Hayashi K. Surgical treatment corner. Points to note before and after bariatric and metabolic surgery from the perspective of a mental health professional. J Jap Soc Treat Obes. 2019;7:20–1 (in Japanese).
224.
Conason A, et al. Substance use following bariatric weight loss surgery. JAMA Surg. 2013;148:145–50.PubMed
225.
Bhatti JA, et al. Self-harm emergencies after bariatric surgery: a population-based cohort study. JAMA Surg. 2016;151:226–32.PubMed
226.
Peterhansel C, et al. Risk of completed suicide after bariatric surgery: a systematic review. Obes Rev. 2013;14:369–82.PubMed
227.
Castaneda D, et al. Risk of Suicide and Self-harm Is Increased After Bariatric Surgery-a Systematic Review and Meta-analysis. Obes Surg. 2019;29:322–33.PubMed
228.
Jakobsen GS, et al. Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities. JAMA. 2018;319:291–301.PubMedPubMedCentral
229.
Pizato N, et al. Effect of Grazing behavior on weight regain post-bariatric surgery: a systematic review. Nutrients. 2017;9:1322.PubMedCentral
230.
Szmulewicz A, et al. Mental health quality of life after bariatric surgery: A systematic review and meta-analysis of randomized clinical trials. Clinical Obesity. 2019;9: e12290.PubMed
231.
Tindle HA, et al. Risk of suicide after long-term follow-up from bariatric surgery. Am J Med. 2010;123:1036–42.PubMedPubMedCentral
232.
Bellicha A, et al. Effective of exercise training after bariatric surgery: a systematic literature review and meta-analysis. Obes Rev. 2018;19:1544–56.PubMed
233.
Daniels P, et al. Effect of a randomised 12-week resistance training program on muscular strength, cross- sec-tional area and muscle quality in women having undergone Roux-en-Y gastric bypass. J Sports Sci. 2018;36:529–35.PubMed
234.
Baillot A, et al. Effects of a pre-surgery supervised exercise training 1 year after bariatric surgery: a randomized controlled study. Obes Surg. 2018;28:955–62.PubMed
235.
Tabesh MR, et al. Nutrition, physical activity, and prescription of supplements in pre- and post-bariatric surgery patients: a practical guideline. Obes Surg. 2019;29:3385–400.PubMed
236.
Nishijima M, et al. Obstructive sleep apnea syndrome associated with severe obesity(preoperative evaluation and management) Metabolic Surgery Clinical Update 66–71. Osaka: Medica Publishing; 2020. (in Japanese).
237.
Kikkawa E, et al. Effect of dietary habits after bariatric surgery on the effect of weight loss. J Jpn Soc Clin Nutr. 2019;41:128–34 (in Japanese).
Metadaten
Titel
Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity
verfasst von
Akira Sasaki
Koutaro Yokote
Takeshi Naitoh
Junji Fujikura
Karin Hayashi
Yushi Hirota
Nobuya Inagaki
Yasushi Ishigaki
Kazunori Kasama
Eri Kikkawa
Hidenori Koyama
Hiroaki Masuzaki
Takeshi Miyatsuka
Takehiro Nozaki
Wataru Ogawa
Masayuki Ohta
Shinichi Okazumi
Michio Shimabukuro
Iichiro Shimomura
Hitoshi Nishizawa
Atsuhito Saiki
Yosuke Seki
Nobuhiro Shojima
Motoyoshi Tsujino
Satoshi Ugi
Hiroaki Watada
Toshimasa Yamauchi
Takashi Yamaguchi
Kohjiro Ueki
Takashi Kadowaki
Ichiro Tatsuno
Joint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, the Japan Society for the Study of Obesity
Publikationsdatum
08.11.2021
Verlag
Springer Singapore
Erschienen in
Diabetology International / Ausgabe 1/2022
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-021-00551-0

Weitere Artikel der Ausgabe 1/2022

Diabetology International 1/2022 Zur Ausgabe

Case Report

Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes

Original Article

Glycemic control and number of natural teeth: analysis of cross-sectional Japanese employment-based dental insurance claims and medical check-up data

Original Article

Vomiting and hyperkalemia are novel clues for emergency room diagnosis of type 1 diabetic ketoacidosis: a retrospective comparison between diabetes types

Original Article

Glycated albumin (GA) and the GA/HbA1c ratio are higher in diabetic patients positive for insulin antibodies with high binding capacity and low affinity

Case Report

Formation of large abscess tumor including gallstone in ileum during therapy for hyperosmolar hyperglycemic syndrome: a case report

Original Article

Variables associated with adherence to the treatment of type 2 diabetes mellitus among elderly people

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise